Unicompartmental Knee Prostheses

Unicompartmental Knee Prostheses

Global Unicompartmental Knee Prostheses Market to Reach US$1.0 Billion by 2030

The global market for Unicompartmental Knee Prostheses estimated at US$841.1 Million in the year 2023, is expected to reach US$1.0 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Fixed Bearing Implants, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$410.4 Million by the end of the analysis period. Growth in the Mobile Bearing Implants segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$229.1 Million While China is Forecast to Grow at 5.6% CAGR

The Unicompartmental Knee Prostheses market in the U.S. is estimated at US$229.1 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$206.3 Million by the year 2030 trailing a CAGR of 5.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 2.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR.

Global Unicompartmental Knee Prostheses Market - Key Trends and Drivers Summarized

Unicompartmental knee prostheses, also known as partial knee replacements, are specialized implants designed to replace only one of the three compartments of the knee joint—either the medial, lateral, or patellofemoral compartment. This surgical option is ideal for patients with osteoarthritis confined to a single compartment, preserving the healthy parts of the knee and maintaining more of the patient’s natural knee structure and function. The procedure involves removing the damaged cartilage and bone in the affected compartment and replacing it with a metal and plastic prosthesis. This approach offers several benefits over total knee replacement, including smaller incisions, less trauma to the bone and surrounding tissues, quicker recovery times, and a more natural knee movement post-surgery.

Technological advancements in unicompartmental knee prostheses have significantly enhanced their design, material composition, and surgical techniques, resulting in better patient outcomes and longer-lasting implants. Modern prostheses are designed with advanced biomaterials that mimic the properties of natural bone and cartilage, providing improved durability and biocompatibility. The use of minimally invasive surgical techniques, aided by computer-assisted navigation and robotic surgery, has improved the precision of implant placement, reduced surgical errors, and minimized postoperative complications. These innovations have also facilitated the development of custom-fit implants tailored to the specific anatomical features of each patient’s knee, further enhancing the functionality and longevity of the prosthesis.

The growth in the unicompartmental knee prostheses market is driven by several factors, including the increasing prevalence of osteoarthritis, particularly among the aging population, and the rising demand for less invasive surgical options that offer quicker recovery and better quality of life. Technological advancements in implant materials and surgical techniques have also played a critical role in expanding the market by improving the efficacy and safety of partial knee replacements. Additionally, growing awareness among patients and healthcare providers about the benefits of unicompartmental knee prostheses over total knee replacements has contributed to their increasing adoption. The expansion of healthcare infrastructure and the availability of advanced surgical facilities in emerging markets are further driving market growth. Regulatory support and favorable reimbursement policies for knee replacement surgeries also encourage the adoption of these innovative implants. Together, these factors ensure the continued expansion and evolution of the unicompartmental knee prostheses market, providing effective solutions for patients with localized knee arthritis and enhancing their overall mobility and quality of life.

Select Competitors (Total 48 Featured) -

• Adler Ortho S.p.A.
• Anika Therapeutics, Inc.
• Bionic
• Biotech GmbH
• Enovis Corporation
• Exactech, Inc.
• Groupe Lépine
• Johnson & Johnson MedTech
• Medacta International
• SERF
• Smith & Nephew plc
• Stryker Corporation
• X.NOV SAS
• Zimed Medikal
• Zimmer Biomet;

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.